CompletedNot Applicable

RSV Antibiotic Drivers And Resource-use

Turkey (Türkiye)209 participantsStarted 2017-04-01

Plain-language summary

This study retrospectively evaluated the clinical, laboratory, and radiologic factors that influence the decision to prescribe antibiotics in children under 2 years of age hospitalized with RSV-positive acute lower respiratory tract infections. The study also examined the economic impact of antibiotic use in these patients. The goal is to improve clinical decision-making and reduce unnecessary antibiotic exposure in children with viral infections.

Who can participate

Age range

1 Month – 24 Months

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age between 1 and 24 months at the time of hospitalization * Laboratory-confirmed RSV positivity via multiplex PCR * Hospitalized for acute lower respiratory tract infection * Complete hospitalization and clinical data available Exclusion Criteria: * Detection of additional respiratory pathogens on multiplex PCR * Discharge against medical advice before treatment was completed * Missing or incomplete key clinical, laboratory, or radiologic data * ICU admission without full follow-up data

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Association between clinical/laboratory/radiologic parameters and antibiotic prescription

Timeframe: During hospitalization (April 2017 - April 2021)

Trial details

NCT IDNCT06977971

SponsorDr. Behcet Uz Children's Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-04-01

View on ClinicalTrials.gov More Respiratory Syncytial Virus Infections trials